secwatch.observer — SEC 8-K summary
======================================

Issuer:     Scienture Holdings, Inc. (SCNX)
CIK:        0001382574
Form:       8-K
Filed at:   2022-10-03T23:59:59+00:00
Accession:  0001493152-22-027358
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TRxADE Health appoints Jeff Newell to Board of Directors, effective Sept 30, 2022
--------------------------------------------------------------------------------

- Jeff Newell appointed to fill board vacancy left by Christine L. Jennings' Aug 26 resignation.
- Newell joins Audit, Compensation, and Nominating/Governance committees.
- Previously served on Advisory Board for $3,000/month; consulting agreement terminated upon appointment.
- Newell brings over 40 years healthcare experience, including CEO at Pharmacy Quality Solutions and Kmart Pharmacy.
- Board now has majority independent directors and fully constituted three-member Audit Committee.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1382574/000149315222027358/0001493152-22-027358-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1382574/000149315222027358/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-027358

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer